[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100598028":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":36,"responsibleParty":63,"collaborators":66,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":73,"acronym":74,"eligibilityCriteria":75,"healthyVolunteers":71,"sex":76,"minAge":77,"maxAge":25,"enrollmentInfo":78,"targetDuration":25,"studyType":81,"phases":82,"briefSummary":84,"conditions":85,"keywords":87,"overallStatus":90,"whyStopped":25,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"Western University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Wearable device group (WDG):","EXPERIMENTAL","Participants who were randomized to the WDG will receive a smart watch and a mobile phone with KinesiaU application loaded. Participants will get hands on training on the first visit about how to use the smartwatch, how to enter medication details and access the reports on the phone. They will be instructed to wear the smartwatch for at least five out of seven days following the first visit.",[13],"Device: Kinesia U",{"label":15,"type":6,"description":16,"interventionNames":17},"control group","Participants in the control group will receive standard of care, consisting of regular management of their motor symptoms and monitoring using motor dairy, interview by their neurologist, family physician, and other healthcare providers. n.",[18],"Other: Standard of care treatment",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","Kinesia U","KinesiaU is a commercially available wearable technology, which includes a smart watch and a mobile application which can continuously monitor and quantify motor symptoms such as tremor, bradykinesia, dyskinesia, gait parameters throughout the day. The technology has been validated for motor symptoms and has high agreement with clinician ratings of motor severity. The motion sensor records data using KinesiaU smart watch and is then transmitted to a secure cloud database, where specialized algorithms analyze the information to detect motor symptoms and compute severity scores every 2 minutes. The results are then not only available to clinicians in the form of detailed reports for review but also for PwP in easily understandable format on the phone application . The validity of this device has been studied to assess tremor, bradykinesia and dyskinesia.",[9],null,{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Standard of care treatment","Participants in the control group will receive standard of care, consisting of regular management of their motor symptoms and monitoring using motor dairy, interview by their neurologist, family physician, and other healthcare providers.",[15],[31],{"name":32,"role":33,"phone":34,"phoneExt":25,"email":35},"deepa dash","CONTACT","15196633187","deepa.dash@lhsc.on.ca",[37,55],{"facility":38,"status":25,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"London Health Sciences Center.London ,Ontario","London","Ontario","N5X 1A4","Canada","CA",{"type":45,"coordinates":46},"Point",[47,48],-81.23304,42.98339,{"lat":48,"lon":47},[51],{"name":52,"role":33,"phone":53,"phoneExt":25,"email":54},"Deepa Dash","5196633187","drddash@yahoo.com",{"facility":56,"status":25,"city":39,"state":40,"zip":57,"country":42,"countryCode":43,"cosmosGeoPoint":58,"geoPoint":60,"contacts":61},"London Health Sciences Center","N6A 5A5",{"type":45,"coordinates":59},[47,48],{"lat":48,"lon":47},[62],{"name":25,"role":33,"phone":53,"phoneExt":25,"email":35},{"type":64,"investigatorFullName":52,"investigatorTitle":65,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Assistant Professor",[67],{"name":68,"class":6},"Academic Medical Organization of Southwestern Ontario","100598028","smart-pd-evaluating-the-impact-of-smartphone-based-wearable-technology-on-motor-symptoms-and-quality-of-life-in-people-with-parkinsons-disease-100598028",false,"NCT07066163","SMART-PD: Evaluating the Impact of Smartphone-Based Wearable Technology on Motor Symptoms and Quality of Life in People With Parkinson's Disease","SMART PD","Inclusion criteria:\n\n* Meet criteria for Parkinson's disease using MDS Clinical Diagnostic Criteria for Parkinson's Disease\n* Presence of Motor fluctuations based on movement disorder neurologist assessment.\n* Motor ability to use the wearable device and access the wearable device application.\n* Cognitively ability to do ADL's and use the wearable device and access the wearable device application based on clinician's judgment.\n* Knowledge of English to enter medication details in the wearable device application.\n\nExclusion criteria:\n\n* Physical barriers in using the wearable device.\n* Atypical Parkinsonian disorder or other causes of Parkinsonism\n* Inability to read or write English.","ALL","40 Years",{"count":79,"type":80},32,"ESTIMATED","INTERVENTIONAL",[83],"NA","This study aims to evaluate whether wearable technology can improve the management of motor symptoms in people with Parkinson's disease (PD) who experience motor fluctuations throughout the day. The project will use a smartwatch and mobile app (KinesiaU) to continuously track movement, allowing for more responsive and personalized treatment compared to traditional monitoring methods.\n\nIn this pilot randomized controlled trial, 32 participants will be assigned to either:\n\nA control group receiving standard care, or\n\nA wearable device group receiving standard care plus using the smartwatch.\n\nOutcomes will be assessed over a 4-week period, focusing on changes in motor function, quality of life, and self-management. The study will also examine feasibility, adherence, and data quality.\n\nIf successful, this trial will provide critical evidence for integrating wearable devices into routine clinical care for PD, paving the way for larger efficacy trials and more patient-centered care strategies.",[86],"Parkinson Disease, Idiopathic",[88,89],"parkinson","wearable","NOT_YET_RECRUITING","2025-07-03",{"date":93,"type":94},"2025-07-15","ACTUAL",{"date":96,"type":80},"2026-01",{"date":98,"type":80},"2029-05",{"name":5,"class":6},2]